Goodwin

We are a firm of insiders driving client value through deep industry knowledge, legal excellence, and business advisory expertise.

[Hivemind @HivemindCap]

Some of the most important breakthroughs in AI and frontier technology never make it beyond the lab.

Federal research funding is declining. Corporate funding often comes with IP concessions. And traditional venture capital typically enters the picture long after the most critical research has been done. Too often, groundbreaking ideas are left without the resources needed to reach the next stage.

That's why we're excited to launch darkmatter lab in partnership with @UCBerkeley , with support from @googlecloud , @GundersonLaw , and @goodwinlaw.

Built for researchers before a company exists, darkmatter lab provides at least $1 million in resources per project, including research funding, compute credits, legal support, and operational expertise.

We're starting with AI and blockchain, supporting work in areas like AI infrastructure, agentic systems, cybersecurity, cryptography, compute optimization, and decentralized technologies.

This is the cornerstone of Hivemind's upcoming venture fund and a new approach to helping transformative research make the leap from academia into the real world.

Learn more: https://t.co/2Y2SYfPE5D

[Glasswing Ventures @GlasswingVC]

What makes an AI company defensible?

We're unpacking it live at Defensible AI during #BOSTechWeek with @HSBC, @goodwinlaw, and @Techstars.

Featuring @rudina11, David Sabow, @ADawesar75992, @J_G_Jeffrey, and more!

May 27th, 9am | Glasswing Office

RSVP: https://t.co/chxwo8Edn9

[Techstars @Techstars]

We're headed to Boston Tech Week! ⭐

If you're building, investing, or just curious about what's next in enterprise AI, this one's worth blocking off your calendar for.

We're teaming up with @GlasswingVC, @goodwinlaw, and @HSBC for conversation on what actually makes AI products stick inside the enterprise.

🛡️ Defensible AI: Building Trust and Resilience in the Enterprise
📆 May 27 at 9:00–11:30am ET
🔗 https://t.co/z08kh6NLsM

Join us at @Techweek_!

[The Deal by S&P Global @TheDealNewsroom]

Listen to the latest Activist Investing Today #podcast with @rorol, where @goodwinlaw partner Leonard Wood discusses #activism trends in REITs and biotech and evolving settlement dynamics. https://t.co/CuLQtYIJRM

[Goodwin @goodwinlaw]

@michellearning Congratulations to the Medra team - this is huge. 🤖

[Goodwin @goodwinlaw]

Congratulations to our friends at @HightouchData for raising the standard on AI-generated creative at scale with their launch of Ad Studio.

[Tejas Manohar @tejasmanohar]

every marketer I talk to is banging their heads against a wall right now

"how do I get AI ads to not be... so bad?"

we just launched Ad Studio @HightouchData

✅ we know your brand
✅ we know your existing creative
✅ we know what works in your ads

ps: you can edit without re-prompting

[Michelle Lee @michellearning]

The next industrial revolution isn’t software. It’s science.

[GC AI @gcai]

The #2026GCAISummit afternoon sessions kick off with M&A Greatness.

Larry Chu, Strategic Advisor, Global Co-chair of Global M&A of @goodwinlaw on why AI is turning M&A deal speed into a strategic advantage, and why the real asset is still people + know-how.

[Ruby Gadelrab @DivaBiotech]

I loving watching my good friend Deepa Rich from @goodwinlaw interview @ChelseaClinton at #JPM2026

[Goodwin @goodwinlaw]

What does legal transformation look like inside a large, established institution—and what happens when you don’t innovate at the right moment?

Keir Gumbs, Chief Legal Officer at Edward Jones, brings a rare 360° view of the legal and regulatory landscape, shaped by experience across major institutions and government. In this episode of Pearls On, Gloves Off, he shares with Mary O’Carroll what it takes to modernize a legal function from within: reshaping how legal, compliance, and risk partner with the business and leading with an “enable first” mindset.

One big takeaway: the job isn’t just protecting the enterprise. It’s enabling it to grow—responsibly.

A timely listen for anyone navigating transformation, governance, and the future of firm partnerships. 🎧

Apple: https://t.co/wORtmNm0qw
Spotify: https://t.co/F0MZKCnRPG

#LegalTransformation #Leadership #LegalOps #Governance

[Goodwin @goodwinlaw]

Announcing a special guest speaker at the Goodwin + KPMG Symposium @ J.P. Morgan.

We’re excited to announce Namandje Bumpus, PhD—strategic advisor, nationally recognized biomedical scientist, and former Principal Deputy Commissioner of the FDA—as a featured speaker.

Dr. Bumpus brings deep experience at the intersection of regulatory science, public health policy, and life sciences innovation. She previously served as the FDA’s second-in-command and now, through Bumpus Advising, partners with organizations on regulatory strategy and scientific engagement. Her work has been recognized at the highest levels of science and public service, including election to the National Academy of Medicine.

📅 January 14, 2026
🕒 PM PT
💬 Fireside Chat: Goodwin and KPMG Chat with Dr. Bumpus on Regulatory & Policy Outlook

Explore the agenda and register to join conversations with leaders across life sciences and healthcare: https://t.co/6gUsBREOvt

#LifeSciences #Healthcare #JPM2026

[Andrew Kim @akhoya87]

Shameless plug: Need CLE credit? Want a CliffsNotes version of the latest gaming law developments?

Join me on January 21 for @goodwinlaw's CLE week, where I'll be presenting Luck Be a Lawyer: Legal Developments in Gambling, Sweepstakes, and Prediction Markets. Link below.

[Bet Tzedek @BetTzedek]

We’re honored to have supported Betsy, with the help of Goodwin Procter LLP, and we’re thrilled that her studio has reopened — once again serving as a place for the community to gather, bond, and grow.

[Goodwin @goodwinlaw]

For the sixth consecutive year, Goodwin has been named the number one law firm in LSEG’s FY 2025 league tables for global M&A by deal count. The firm also secured the number one position in United States M&A – by deal count – for announced and completed deals.

Learn more: https://t.co/67kjZmhBp5

#MergersAndAcquisitions

[Goodwin @goodwinlaw]

Announcing Our Keynote at Goodwin + KPMG Symposium @ J.P. Morgan

We’re thrilled to announce Clive Meanwell, M.B., Ch.B., M.D.—biotech founder, cancer researcher, and industry icon—as our keynote speaker.

Clive has built and scaled some of the most enduring companies in life sciences, from The Medicines Company (acquired by Novartis for $9.7B) to Metsera (Pfizer acquisition pending at over $10B). In this keynote conversation, he’ll share hard-won insights on leadership, scientific innovation, capital strategy, and M&A—and what it truly takes to build biotech companies that last.

📅 January 14, 2026
🕐 1:00 PM PT
🎤 A Conversation with Clive Meanwell on Leadership, Innovation, M&A, and Building Biotech Companies That Last

Explore the full agenda and register to connect with leading voices from across life sciences and healthcare: https://t.co/GyQSFWHAP2

#LifeSciences #Healthcare #JPM2026